Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.

Journal article

Shamanna RA. et al, (2016), Oncotarget, 7, 13269 - 13284

RECQL4 helicase has oncogenic potential in sporadic breast cancers.

Journal article

Arora A. et al, (2016), The Journal of pathology, 238, 495 - 501

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis.

Journal article

Abdel-Fatah TMA. et al, (2016), Clinical cancer research : an official journal of the American Association for Cancer Research, 22, 905 - 914

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.

Journal article

Aleskandarany MA. et al, (2016), Breast cancer research and treatment, 156, 9 - 20

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.

Journal article

Arora A. et al, (2016), Carcinogenesis, 37, 63 - 71

Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.

Journal article

Abdel-Fatah TMA. et al, (2015), Molecular oncology, 9, 569 - 585

Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.

Journal article

Abdel-Fatah TMA. et al, (2014), Neoplasia (New York, N.Y.), 16, 982 - 991

Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.

Journal article

Perry C. et al, (2014), Oncotarget, 5, 5764 - 5781